Chemomab Therapeutics (CMMB) Research & Development (2017 - 2026)
Chemomab Therapeutics (CMMB) reported Research & Development of $1.14 million for Q2 2026, down 11.3% from $1.29 million a year earlier but up 23.5% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Research & Development (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Chemomab Therapeutics' Research & Development came in at $4.12 million, down 54.4% year-over-year; for FY2025, it came in at $5.83 million, down 48.5% from FY2024.
- Research & Development has a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
- By year, Research & Development came in at $11.33 million in FY2024 (-38.4%), $18.38 million in FY2023 (+8.3%), $16.98 million in FY2022 (+168.0%) and $6.33 million in FY2021 (+35.2%).
- Five-year quarterly Research & Development spans a low of $925,000 in Q1 2026 and a high of $6.89 million in Q1 2023.
- Year over year, Research & Development has now declined in each of the last 12 quarters, with an average decline of 38.8% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q3 2022 (growth of 264.7%); the low point was Q3 2025 (a decline of 66.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $925,000 (Q1 2026), $1.09 million (Q4 2025) and $960,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Chemomab Therapeutics | 11.80 Mn | 11.80 Mn | - | 1.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 925,000.00 |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 960,000.00 |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | 2.93 Mn |
| Mar 31, 2024 | 3.15 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 5.02 Mn |
| Mar 31, 2023 | 6.89 Mn |
| Dec 31, 2022 | 5.90 Mn |
| Sep 30, 2022 | 5.42 Mn |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 2.38 Mn |
| Sep 30, 2021 | 1.49 Mn |
API Access
Chemomab Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();